Keyword Connections

durvalumab

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

6

1 Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors

2 durvalumab: an investigational anti-pd-l1 monoclonal antibody for the treatment of urothelial carcinoma

3 anti pd-l1 durvalumab combined with cetuximab and radiotherapy in locally advanced squamous cell carcinoma of the head and neck: a phase i/ii study (ducro)

4 A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).

5 Avelumab induces greater Fc-Fc receptor-dependent natural killer cell activation and dendritic cell crosstalk compared to durvalumab.

6 Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival.